Immuron

+$0.11 (+3.06%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.

CEO

Jerry Kanellos

Employees

—

Headquarters

Carlton, Victoria (VIC)

Founded

1994

IMRN Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

5.14M

High today

$3.72

Low today

$3.36

Open price

$3.36

Volume

434.35K

52 Week high

$9.23

52 Week low

$2.32

IMRN News

Simply Wall StJan 21

We Think Immuron Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money

IMRN Earnings

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Feb 23, Pre-Market